A Podcast on Patient and Physician Perspectives on the Management of Endometriosis and Relugolix Combination Therapy

Adv Ther. 2024 Dec;41(12):4369-4376. doi: 10.1007/s12325-024-02970-2. Epub 2024 Oct 19.

Abstract

Endometriosis is a common disease, affecting approximately 5-10% of reproductively aged women. Symptoms, such as painful periods, negatively impact an individual's quality of life; however, these symptoms are often normalized, leading to delays in diagnosis and treatment, and worsening of the disease. In this podcast, a reproductive endocrinologist (Dr Sanjay K Agarwal) and patient advocate (Tara Mangum) provide their perspectives on the diagnosis and management of endometriosis. They also discuss Relugolix combination therapy as a treatment option for patients with endometriosis.Podcast available for this article.

Keywords: Endometriosis; GnRH antagonists; Quality of life; Relugolix combination therapy.

MeSH terms

  • Endometriosis* / drug therapy
  • Endometriosis* / therapy
  • Female
  • Humans
  • Levonorgestrel / administration & dosage
  • Levonorgestrel / therapeutic use
  • Quality of Life
  • Webcasts as Topic

Substances

  • Levonorgestrel